Lexeo Therapeutics, Inc. (LXEO) ROA
- 2026-06-30: ROA -34.24%.
- 2026-03-31: ROA -34.95%.
- 2025-12-31: ROA -37.20%.
- 2025-09-30: ROA -72.97%.
Complete source-backed roa history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -34.24% |
| 2026-03-31 | -34.95% |
| 2025-12-31 | -37.20% |
| 2025-09-30 | -72.97% |
| 2025-06-30 | -64.85% |
| 2025-03-31 | -86.97% |
| 2024-12-31 | -66.92% |
| 2024-09-30 | -49.81% |
| 2024-06-30 | -40.21% |
| 2024-03-31 | -32.56% |
| 2023-12-31 | -47.49% |
| 2023-09-30 | -122.04% |
| 2022-12-31 | -61.06% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -37.20% |
| 2024-12-31 | -66.92% |
| 2023-12-31 | -47.49% |
| 2022-12-31 | -61.06% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |